Podzamczer Palter, D., Micán, R., Tiraboschi, J. M., Portilla, J., Domingo, P. (. P., Llibre, J. M., . . . Investigators, S. S. (2021). Darunavir/cobicistat/emtricitabine/tenofovir alafenamide versus dolutegravir /abacavir/lamivudine in antiretroviral-naïve adults (SYMTRI): A multicenter randomized open-label study (PReEC/RIS-57).
Citación estilo ChicagoPodzamczer Palter, Daniel, et al. Darunavir/cobicistat/emtricitabine/tenofovir Alafenamide Versus Dolutegravir /abacavir/lamivudine in Antiretroviral-naïve Adults (SYMTRI): A Multicenter Randomized Open-label Study (PReEC/RIS-57). 2021.
Cita MLAPodzamczer Palter, Daniel, et al. Darunavir/cobicistat/emtricitabine/tenofovir Alafenamide Versus Dolutegravir /abacavir/lamivudine in Antiretroviral-naïve Adults (SYMTRI): A Multicenter Randomized Open-label Study (PReEC/RIS-57). 2021.